We are live on ! Find out more
KALV

KalVista Pharmaceuticals
KALV

Delisted

KALV was delisted on the 10th of June, 2026.

Back to rankings

41 hedge funds and large institutions have $84.1M invested in KalVista Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$19.9M
3
Franklin Resources
Franklin Resources
California
+$10.8M
4
BC
Broadfin Capital
New York
+$8.36M
5
PI
Putnam Investments
Massachusetts
+$4.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$23.6M +$23.4M +236,195 New
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$20M +$19.9M +200,236 New
Franklin Resources
3
Franklin Resources
California
$10.9M +$10.8M +108,864 New
BC
4
Broadfin Capital
New York
$8.43M +$8.36M +84,210 New
PI
5
Putnam Investments
Massachusetts
$4.54M +$4.5M +45,341 New
SFM
6
Sphera Funds Management
Israel
$2.86M +$2.83M +28,571 New
BFA
7
BlackRock Fund Advisors
California
$2.33M +$2.31M +23,296 New
PCM
8
Pentwater Capital Management
Florida
$1.61M +$1.59M +16,071 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.61M +$1.6M +16,079 New
PAM
10
Panagora Asset Management
Massachusetts
$1.48M +$1.47M +14,797 New
Goldman Sachs
11
Goldman Sachs
New York
$1.21M +$1.2M +12,072 New
OA
12
Omega Advisors
New York
$715K +$709K +7,143 New
Alyeska Investment Group
13
Alyeska Investment Group
Illinois
$714K +$708K +7,133 New
State Street
14
State Street
Massachusetts
$557K +$553K +5,569 New
BIT
15
BlackRock Institutional Trust
California
$549K +$544K +5,480 New
TD Asset Management
16
TD Asset Management
Ontario, Canada
$520K +$515K +5,193 New
TCIM
17
TIAA CREF Investment Management
New York
$463K +$459K +4,629 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$331K +$328K +3,309 New
BIM
19
BlackRock Investment Management
Delaware
$309K +$306K +3,083 New
PVI
20
Pura Vida Investments
New York
$276K +$283K +2,857 New
Northern Trust
21
Northern Trust
Illinois
$209K +$207K +2,083 New
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$160K +$159K +1,600 New
TA
23
Teachers Advisors
New York
$126K +$125K +1,259 New
Charles Schwab
24
Charles Schwab
California
$113K +$112K +1,125 New
VKH
25
Virtu KCG Holdings
New York
$87K +$86.6K +873 New
1
2

KALV Hedge Fund Activity: Q2 2015 in Review

41 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in KalVista Pharmaceuticals (KALV) for Q2 2015, worth a combined $84.1M.

Buyers outnumbered sellers: 41 funds opened new KALV positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $23.4M.

  • 41 institutional investors held KalVista Pharmaceuticals (KALV) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $84.1M of KalVista Pharmaceuticals stock for Q2 2015.
  • 41 funds opened new KalVista Pharmaceuticals positions in Q2 2015 and 0 closed out, a net change of +41 holders.
  • The largest KalVista Pharmaceuticals buyer in Q2 2015 was Fidelity Investments, an estimated $23.4M added.

Based on aggregated 13F filings for Q2 2015.